Michel Geist
Inventor
Stats
- 7 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 9 US Applications Filed
- 99 Total Citation Count
- Dec 23, 2019 Most Recent Filing
- Apr 12, 2001 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Transgene S.A. | 2
2 2 2 4 1 1 | 2001
2004 2009 2011 2013 2015 2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| Brumath, FR | Sep 22, 05 - Oct 10, 23 |
| Lingolsheim, FR | Sep 04, 03 - Apr 08, 08 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11779619 | 2023 | Oncolytic virus for expression of immune checkpoint modulators | 0 |
| 2020/0197,457 | 2020 | ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS | 0 |
| 10555981 | 2020 | Oncolytic virus for expression of immune checkpoint modulators | 2 |
| 9982055 | 2018 | Antibody against the CSF-1R | 1 |
| 2017/0157,188 | 2017 | ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS | 30 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.